The FDA’s approval of CBD-based Epidiolex and its potential implications

As of this summer, medical marijuana is legal in 30 states and Washington, D.C. Nine of those states, plus D.C., have also legalized marijuana for recreational purposes. Although the federal government has not been as quick in its acceptance of cannabis, it’s clear that the cultural perception of the drug is changing.

Perhaps nowhere is this more evident than in a recent decision by the FDA to approve Epidiolex, the first prescription drug to be derived from the marijuana plant. The medication was approved as a treatment for Lennox-Gastaut syndrome and Dravet syndrome, both rare forms of epilepsy that begin in childhood.

Read The Rest of This Article Here!

Leave a Reply

Your email address will not be published. Required fields are marked *